SMTL ID : 1fi1.1

FhuA in complex with lipopolysaccharide and rifamycin CGP4832

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

monomer

Ligands

1 x PA1- GCN- KDO- GMH- GMH- GLC- GLC- GLC- GLA- GMH- KDO: alpha-D-glucopyranose-(1-2)-alpha-D-glucopyranose-(1-3)-[alpha-D-galactopyranose-(1-6)]alpha-D-glucopyranose-(1-3)-[L-glycero-alpha-D-manno-heptopyranose-(1-7)]L-glycero-alpha-D-manno-heptopyranose-(1-3)-L-glycero-alpha-D-manno-heptopyranose-(1-5)-[3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid-(2-4)]3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid-(2-6)-2-amino-2,3-dideoxy-alpha-D-glucoyranose-(1-6)-2-amino-2-deoxy-alpha-D-glucopyranose(Non-functional Binders)

PA1-GCN-KDO-GMH-GMH-GLC-GLC-GLC-GLA-GMH-KDO.1: 19 residues within 4Å: Chain A: D.331, K.333, Q.335, R.364, R.366, D.368, N.370, R.417, L.419, R.456 Ligands: FTT.2, PO4.3, PO4.4, NI.5, FTT.8, FTT.9, FTT.11, DPO.13, DPO.14 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.364, A:R.417 Water bridges: A:D.331, A:R.366, A:R.366 Salt bridges: A:R.366, A:R.364, A:R.366, A:K.421

6 x FTT: 3-HYDROXY-TETRADECANOIC ACID(Non-covalent)(Non-functional Binders)

FTT.2: 12 residues within 4Å: Chain A: F.211, F.213, V.264, G.265, Y.266, F.284, R.364 Ligands: PA1-GCN-KDO-GMH-GMH-GLC-GLC-GLC-GLA-GMH-KDO.1, PA1-GCN-KDO-GMH-GMH-GLC-GLC-GLC-GLA-GMH-KDO.1, FTT.9, FTT.10, FTT.11 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:F.211, A:F.213, A:F.213, A:V.264, A:Y.266, A:F.284, A:F.284, A:F.284, A:F.284 Hydrogen bonds: A:R.364, A:R.364 FTT.8: 10 residues within 4Å: Chain A: Y.266, Q.280, F.337, F.362, R.364 Ligands: PA1-GCN-KDO-GMH-GMH-GLC-GLC-GLC-GLA-GMH-KDO.1, FTT.9, FTT.10, DPO.13, DDQ.16 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:F.337, A:F.362 FTT.9: 4 residues within 4Å: Ligands: PA1-GCN-KDO-GMH-GMH-GLC-GLC-GLC-GLA-GMH-KDO.1, FTT.2, FTT.8, FTT.10 No protein-ligand interaction detected (PLIP) FTT.10: 7 residues within 4Å: Chain A: Y.266, L.282, F.337, R.364 Ligands: FTT.2, FTT.8, FTT.9 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:L.282 Hydrogen bonds: A:R.364 FTT.11: 8 residues within 4Å: Chain A: F.213, F.284, E.286, Q.335 Ligands: PA1-GCN-KDO-GMH-GMH-GLC-GLC-GLC-GLA-GMH-KDO.1, FTT.2, PO4.3, FTT.12 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:F.213, A:F.284, A:F.284 Hydrogen bonds: A:E.286 FTT.12: 7 residues within 4Å: Chain A: P.199, F.217, V.264, F.284, E.286 Ligands: PO4.3, FTT.11 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:P.199, A:F.217, A:V.264, A:F.284

2 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.3: 7 residues within 4Å: Chain A: E.286, K.333, Q.335 Ligands: PA1-GCN-KDO-GMH-GMH-GLC-GLC-GLC-GLA-GMH-KDO.1, PA1-GCN-KDO-GMH-GMH-GLC-GLC-GLC-GLA-GMH-KDO.1, FTT.11, FTT.12 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.286, A:Q.335 Salt bridges: A:K.333 PO4.4: 2 residues within 4Å: Ligands: PA1-GCN-KDO-GMH-GMH-GLC-GLC-GLC-GLA-GMH-KDO.1, NI.5 No protein-ligand interaction detected (PLIP)

1 x NI: NICKEL (II) ION(Non-functional Binders)

NI.5: 2 residues within 4Å: Ligands: PA1-GCN-KDO-GMH-GMH-GLC-GLC-GLC-GLA-GMH-KDO.1, PO4.4 No protein-ligand interaction detected (PLIP)

1 x NA: SODIUM ION(Non-functional Binders)

NA.6: 7 residues within 4Å: Chain A: P.29, L.439, V.440, T.441, G.474, V.475, N.476 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:T.441, A:T.441, A:N.476

1 x MG: MAGNESIUM ION(Non-covalent)

MG.7: 4 residues within 4Å: Chain A: R.464, D.466, K.467, Q.468 No protein-ligand interaction detected (PLIP)

2 x DPO: DIPHOSPHATE(Non-covalent)(Non-functional Binders)

DPO.13: 4 residues within 4Å: Chain A: K.421, K.423 Ligands: PA1-GCN-KDO-GMH-GMH-GLC-GLC-GLC-GLA-GMH-KDO.1, FTT.8 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:R.366 Water bridges: A:K.421, A:K.421 Salt bridges: A:K.421, A:K.421, A:K.423 DPO.14: 3 residues within 4Å: Ligands: PA1-GCN-KDO-GMH-GMH-GLC-GLC-GLC-GLA-GMH-KDO.1, PA1-GCN-KDO-GMH-GMH-GLC-GLC-GLC-GLA-GMH-KDO.1, PA1-GCN-KDO-GMH-GMH-GLC-GLC-GLC-GLA-GMH-KDO.1 No protein-ligand interaction detected (PLIP)

1 x RIF: RIFAMYCIN CGP 4832(Non-covalent)

RIF.15: 17 residues within 4Å: Chain A: E.80, G.81, Q.82, S.83, F.97, Y.98, Y.226, W.228, Y.295, Y.297, K.326, F.373, G.374, Y.416, Q.498, F.686, Y.689 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:F.97, A:W.228, A:K.326, A:F.373, A:F.373, A:Y.416, A:Y.416, A:F.686, A:F.686 Hydrogen bonds: A:Y.295, A:Y.297, A:Q.498, A:Y.689 Water bridges: A:Y.98, A:W.228 pi-Stacking: A:W.228

1 x DDQ: DECYLAMINE-N,N-DIMETHYL-N-OXIDE(Non-covalent)

DDQ.16: 5 residues within 4Å: Chain A: Q.280, T.341, F.362, T.425 Ligands: FTT.8 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:F.362 Water bridges: A:K.423

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ferguson, A.D. et al., Active transport of an antibiotic rifamycin derivative by the outer-membrane protein FhuA. Structure (2001)

Release Date

2001-08-29

Peptides

FERRICHROME-IRON RECEPTOR: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

FERRICHROME-IRON RECEPTOR